Granulotec® Root Canal Sealer
-
Brand: PD (Switzerland)
-
Type: Eugenol-Free, Bactericidal, Non-Resorbable, Radiopaque Root Canal Sealer
-
Packaging: 20g Powder + 15ml Liquid
-
Shelf Life: 2 years from production date
Description:
Granulotec® is a eugenol-free, radiopaque paste (powder + liquid) designed for the permanent obturation of infected root canals, particularly in the presence of granuloma. Its bactericidal and non-resorbable properties ensure effective healing and long-term sealing of the root canal system.Dental Stall+8Dental Prod+8Humayun Dental Supplies+8
Key Features:
-
Eugenol-Free: Reduces the risk of irritation and allergic reactions.
-
Bactericidal: Eliminates residual bacteria within the canal.
-
Non-Resorbable: Maintains integrity over time without dissolving.
-
Radiopaque: Provides clear visibility on radiographs for accurate assessment.
-
Promotes Healing: Facilitates the resorption of granuloma and regeneration of periapical tissues.
-
Versatile Use: Suitable for both infected and non-infected (vital) teeth.
-
Ease of Use: Allows direct coronal obturations with composites and easy re-reaming if necessary.Universal Dental (Pvt) Ltd.+8New Dental+8New Dental+8New Dental+6DentaCarts+6Doctor Order+6Dental Prod+4Doctor Order+4DentaCarts+4
Composition:
-
Active Ingredients: Dexamethasone Acetate (0.1%), Phenol, Formaldehyde, Guaiacol, Iodoform.
-
Excipient: Specially formulated base to ensure optimal consistency and performance.New Dental+2Dental Prod+2New Dental+2
Clinical Efficacy:
A clinical study evaluating the use of Granulotec® for one-visit treatment of chronic apical periodontitis demonstrated a success rate of 91.4%, with significant bone remodeling observed in the majority of cases .
Application:
Granulotec® is indicated for the permanent obturation of root canals, especially in cases involving apical granulomas. Its properties make it suitable for use in both infected and non-infected teeth, ensuring effective sealing and promoting periapical healing.






Reviews
There are no reviews yet.